Layoffs
Filter News
Found 206 articles
-
More than 600 employees will lose their jobs as the companies reshape their corporate strategies.
-
AirXpanders® Announces Reduction in Force and Plan to Cease Operations
7/17/2019
AirXpanders, Inc., a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, announced that the Company has reduced its workforce and plans to cease operations.
-
In addition to the layoffs, Acer said it has halted pre-commercial activities surrounding Edsivo due to the FDA's rejection last month.
-
Help us identify the leading employers in the life science industry! We want to uncover who leads in key areas like diversity, culture, unique benefits and, of course, who are the 2019 Life Sciences Ideal Employers.
-
Merrimack CEO and CFO Resign
7/2/2019
A month after beleaguered Merrimack Pharmaceuticals announced it was terminating its staff and leadership team, the company’s chief executive officer and chief financial officer have resigned their positions. But, they are both remaining with the company as high-paid consultants. -
Two months after taking over as interim chief executive officer of Bay Area-based uBiome, John Rakow is stepping down from the company that has been under scrutiny from the Federal Bureau of Investigation (FBI).
-
Financial details of the deal were not disclosed, but Lonza said it plans to retain the Novartis employees currently working at the facility.
-
Following an operational review, ImmunoGen will prioritize continued development of mirvetuximab, as well as a select portfolio of three earlier-stage product candidates.
-
Conatus indicated that it is considering a sale of the company as part of an exploration of strategic alternatives. It is already implementing a restructuring plan that will cut 40% of staff and suspend development of its inflammasome compound CTS-2090.
-
The intention is to focus its research efforts on cancer, immunology, rare diseases and vaccines. The changes will result in the loss of 466 jobs in the two countries.
-
Hundreds lose their jobs as companies close facilities and shift business focuses.
-
Merrimack said the company will preserve its cash runway in order to provide time for additional milestone payments from Ipsen.
-
Dynavax plans to step away from immuno-oncology development and will lay off 37% of its staff as a result.
-
Today has been marked by a wide range of life science and biopharma stories. Here’s a broader look at some of the top stories.
-
FamilyTreeDNA and San Diego Police Sex Crimes Unit Collaboration Leads to the Arrest of Suspected Serial Rapist
5/7/2019
FamilyTreeDNA partnered with detectives in the San Diego Police Department Sex Crimes Unit to help identify a suspected serial rapist using investigative genetic genealogy.
-
Merck & Co. filed with the U.S. Securities and Exchange Commission that it plans an extensive restructuring of its manufacturing and supply network. This will, it indicates, reduce its “global real estate footprint.”
-
Retractable Technologies, Inc., Responds to Concerning Statements on Social Media
4/30/2019
It has been brought to our attention that one of our employees made harassing comments to a family who was the victim of violence.
-
The employees were terminated over allegations of industrial espionage on behalf of the Chinese government. MD Anderson ought to quell concerns of racial profiling following the firings.
-
Steps have been taken to safeguard the cancer center, including development of a cutting-edge approach to Enterprise Risk Management.
-
There is something of a recurring theme among the life science, healthcare and biopharma industries: shortage of skilled employees will lead to a decrease in innovation.